UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Study on laser welding of fuel clad tubes and end plugs made of modified 9Cr–1Mo steel for metallic fuel of Fast Breeder Reactors

Journal of nuclear materials, 2013-04, Vol.435 (1-3), p.32-40

2013

Volltextzugriff (PDF)

A “FUNCTIONAL CURE” MAY BE ACHIEVABLE IN A SUBSET OF PATIENTS WITH FOLLICULAR LYMPHOMA TREATED WITH CHEMOIMMUNOTHERAPY: 15‐YEAR FOLLOW‐UP OF PHASE III SWOG‐S0016

Hematological oncology, 2023-06, Vol.41 (S2), p.116-117

2023

Volltextzugriff (PDF)

Response‐adapted mosunetuzumab for untreated follicular and marginal zone lymphomas: significant monotherapy activity seen in results of an interim efficacy analysis

Hematological oncology, 2023-06, Vol.41 (S2), p.577-578

2023

Volltextzugriff (PDF)

INMIND: A PHASE 3 STUDY OF TAFASITAMAB + LENALIDOMIDE AND RITUXIMAB VS PLACEBO + LENALIDOMIDE AND RITUXIMAB FOR RELAPSED/REFRACTORY FOLLICULAR OR MARGINAL ZONE LYMPHOMA

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

HIGH EFFICACY AND FAVORABLE SAFETY OF 3RD GENERATION CD20 CAR‐T (MB‐106) FOR OUTPATIENT TREATMENT OF FOLLICULAR LYMPHOMA (FL)—RESULTS OF A SINGLE‐INSTITUTION TRIAL

Hematological oncology, 2023-06, Vol.41 (S2), p.87-88

2023

Volltextzugriff (PDF)

P1103: INMIND: A PHASE 3 STUDY OF TAFASITAMAB PLUS LENALIDOMIDE AND RITUXIMAB VERSUS PLACEBO PLUS LENALIDOMIDE AND RITUXIMAB FOR RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (FL) OR MARGINAL ZONE LYMPHOMA (MZL)

HemaSphere, 2022-06, Vol.6 (Suppl), p.993-994

2022

Volltextzugriff (PDF)

Minimal detectable disease confirmed by flow cytometry and poor outcome after autologous stem cell transplantation in peripheral T-Cell lymphomas

Bone marrow transplantation (Basingstoke), 2016-12, Vol.51 (12), p.1617-1619

2016

Volltextzugriff (PDF)

P1276: DOSE RESPONSE PROFILE OF IGM‐2323, A CD20XCD3 IGM BISPECIFIC T CELL ENGAGER, IN TRANSLATIONAL MODELS SUPPORTS PHASE 2 DOSE SELECTION IN NON‐HODGKIN'S LYMPHOMA

HemaSphere, 2022-06, Vol.6 (Suppl), p.1161-1162

2022

Volltextzugriff (PDF)

P1115: A MULTICENTER PHASE 1/2 TRIAL OF EO2463, A MICROBIAL‐DERIVED PEPTIDE THERAPEUTIC VACCINE, AS MONOTHERAPY AND IN COMBINATION WITH LENALIDOMIDE AND RITUXIMAB, FOR TREATMENT OF PATIENTS WITH INDOLENT NHL

HemaSphere, 2022-06, Vol.6 (Suppl), p.1005-1006

2022

Volltextzugriff (PDF)

Effect of energy transfer modes on solidification cracking in pulsed laser welding

Science and technology of welding and joining, 2015-10, Vol.20 (7), p.578-584

2015

Volltextzugriff (PDF)

Optimal temperature profiles for minimum residual stress in the cure process of polymer composites

Composite structures, 2000, Vol.48 (1), p.99-106

2000

Volltextzugriff (PDF)

Sensor development for position detection of diverse safety rod of fast reactor

Annals of nuclear energy, 2012-08, Vol.46, p.189-196

2012

Volltextzugriff (PDF)

Pilot Prognostic Model for Survival in r/r DLBCL Patients Receiving Palliative Radiation Therapy

International journal of radiation oncology, biology, physics, 2021-11, Vol.111 (3), p.e299-e300

2021

Volltextzugriff (PDF)

434 AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA AND SMALL LYMPHOCYTIC LYMPHOMA: THE SEATTLE EXPERIENCE

Journal of investigative medicine, 2006-01, Vol.54 (1), p.S154-S154

2006

Volltextzugriff (PDF)

Energy Transfer Modes in Pulsed Laser Seam Welding

Materials and manufacturing processes, 2015-02, Vol.30 (2), p.162-168

2015

Volltextzugriff (PDF)

TiO2 Nanotube Arrays: Synthesis, Properties, and Applications

1. Aufl., 2009

Volltextzugriff (PDF)

TREATMENT EMERGENT ADVERSE EVENTS VARY WITH DIFFERENT PI3K INHIBITORS

Hematological oncology, 2019-06, Vol.37 (S2), p.523-524

2019

Volltextzugriff (PDF)

inMIND: A phase 3 study of tafasitamab plus lenalidomide and rituximab versus placebo plus lenalidomide and rituximab for relapsed/refractory follicular or marginal zone lymphoma

JOURNAL OF CLINICAL ONCOLOGY, 2022, Vol.40 (16_suppl), p.TPS7583-TPS7583

2022

Volltextzugriff (PDF)

SAFETY OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT IN ADULTS AFTER CD19 TARGETED CHIMERIC ANTIGEN RECEPTOR‐MODIFIED T‐CELL (CAR‐T) THERAPY

Hematological oncology, 2019-06, Vol.37 (S2), p.313-314

2019

Volltextzugriff (PDF)

A phase 3 study to evaluate the efficacy and safety of tafasitamab plus lenalidomide and rituximab versus placebo plus lenalidomide and rituximab in patients with relapsed/refractory (R/R) follicular lymphoma (FL) or marginal zone lymphoma (MZL)

JOURNAL OF CLINICAL ONCOLOGY, 2021, Vol.39 (15_suppl), p.TPS7568-TPS7568

2021

Volltextzugriff (PDF)

PEMBROLIZUMAB WITH RCHOP IN PREVIOUSLY UNTREATED DIFFUSE LARGE B‐CELL AND GRADE 3B FOLLICULAR LYMPHOMA: FINAL RESULTS OF A PHASE I TRIAL

Hematological oncology, 2019-06, Vol.37 (S2), p.120-121

2019

Volltextzugriff (PDF)

A WINDOW STUDY OF IXAZOMIB IN UNTREATED B‐NHL

Hematological oncology, 2019-06, Vol.37 (S2), p.570-571

2019

Volltextzugriff (PDF)

A PILOT TRIAL OF ADRIAMYCIN, PEMBROLIZUMAB, VINBLASTINE AND DACARBAZINE (APVD) FOR PATIENTS WITH UNTREATED CLASSICAL HODGKIN LYMPHOMA

Hematological oncology, 2019-06, Vol.37 (S2), p.572-573

2019

Volltextzugriff (PDF)

Isolation and Biochemical Characterization of Lactic Acid Bacteria from Fermented Foods

International journal of current microbiology and applied sciences, 2021-10, Vol.10 (10), p.584-600

2021

Volltextzugriff (PDF)

1 – 25 von 6.361

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(4.397)
Mit Volltextzugriff
(5.156)

Publikationsform

6 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(2.797)
Life Sciences & Biomedicine
(1.101)
Technology
(1.095)
Physical Sciences
(1.068)
Physics
(542)
Engineering
(465)
Materials Science
(446)
Exact Sciences And Technology
(401)
Chemistry
(395)
Materials Science, Multidisciplinary
(358)
Computer Science
(242)
Science & Technology - Other Topics
(233)
Physics, Applied
(224)
Biological And Medical Sciences
(186)
Engineering, Electrical & Electronic
(185)
Applied Sciences
(165)
Agriculture
(162)
Environmental Sciences & Ecology
(152)
Physics, Condensed Matter
(143)
Chemistry, Physical
(140)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(179)
Physical Review Letters
(93)
Current Science
(48)
International Journal Of Mch And Aids
(38)
Total Quality Management
(38)
Cheminform
(36)
Total Quality Management & Business Excellence
(33)
Ssrn Electronic Journal
(32)
Journal Of Clinical Oncology
(29)
Fishery Technology
(28)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Study on laser welding of fuel clad tubes and end plugs made of modified 9Cr–1Mo steel for metallic fuel of Fast Breeder Reactors

A “FUNCTIONAL CURE” MAY BE ACHIEVABLE IN A SUBSET OF PATIENTS WITH FOLLICULAR LYMPHOMA TREATED WITH CHEMOIMMUNOTHERAPY: 15‐YEAR FOLLOW‐UP OF PHASE III SWOG‐S0016

Response‐adapted mosunetuzumab for untreated follicular and marginal zone lymphomas: significant monotherapy activity seen in results of an interim efficacy analysis

INMIND: A PHASE 3 STUDY OF TAFASITAMAB + LENALIDOMIDE AND RITUXIMAB VS PLACEBO + LENALIDOMIDE AND RITUXIMAB FOR RELAPSED/REFRACTORY FOLLICULAR OR MARGINAL ZONE LYMPHOMA

HIGH EFFICACY AND FAVORABLE SAFETY OF 3RD GENERATION CD20 CAR‐T (MB‐106) FOR OUTPATIENT TREATMENT OF FOLLICULAR LYMPHOMA (FL)—RESULTS OF A SINGLE‐INSTITUTION TRIAL

P1103: INMIND: A PHASE 3 STUDY OF TAFASITAMAB PLUS LENALIDOMIDE AND RITUXIMAB VERSUS PLACEBO PLUS LENALIDOMIDE AND RITUXIMAB FOR RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (FL) OR MARGINAL ZONE LYMPHOMA (MZL)

Minimal detectable disease confirmed by flow cytometry and poor outcome after autologous stem cell transplantation in peripheral T-Cell lymphomas

P1276: DOSE RESPONSE PROFILE OF IGM‐2323, A CD20XCD3 IGM BISPECIFIC T CELL ENGAGER, IN TRANSLATIONAL MODELS SUPPORTS PHASE 2 DOSE SELECTION IN NON‐HODGKIN'S LYMPHOMA

P1115: A MULTICENTER PHASE 1/2 TRIAL OF EO2463, A MICROBIAL‐DERIVED PEPTIDE THERAPEUTIC VACCINE, AS MONOTHERAPY AND IN COMBINATION WITH LENALIDOMIDE AND RITUXIMAB, FOR TREATMENT OF PATIENTS WITH INDOLENT NHL

Effect of energy transfer modes on solidification cracking in pulsed laser welding

Optimal temperature profiles for minimum residual stress in the cure process of polymer composites

Sensor development for position detection of diverse safety rod of fast reactor

Pilot Prognostic Model for Survival in r/r DLBCL Patients Receiving Palliative Radiation Therapy

434 AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA AND SMALL LYMPHOCYTIC LYMPHOMA: THE SEATTLE EXPERIENCE

Energy Transfer Modes in Pulsed Laser Seam Welding

TiO2 Nanotube Arrays: Synthesis, Properties, and Applications

TREATMENT EMERGENT ADVERSE EVENTS VARY WITH DIFFERENT PI3K INHIBITORS

inMIND: A phase 3 study of tafasitamab plus lenalidomide and rituximab versus placebo plus lenalidomide and rituximab for relapsed/refractory follicular or marginal zone lymphoma

SAFETY OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT IN ADULTS AFTER CD19 TARGETED CHIMERIC ANTIGEN RECEPTOR‐MODIFIED T‐CELL (CAR‐T) THERAPY

A phase I/II trial of iodine-131–tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas

A phase 3 study to evaluate the efficacy and safety of tafasitamab plus lenalidomide and rituximab versus placebo plus lenalidomide and rituximab in patients with relapsed/refractory (R/R) follicular lymphoma (FL) or marginal zone lymphoma (MZL)

PEMBROLIZUMAB WITH RCHOP IN PREVIOUSLY UNTREATED DIFFUSE LARGE B‐CELL AND GRADE 3B FOLLICULAR LYMPHOMA: FINAL RESULTS OF A PHASE I TRIAL

A WINDOW STUDY OF IXAZOMIB IN UNTREATED B‐NHL

A PILOT TRIAL OF ADRIAMYCIN, PEMBROLIZUMAB, VINBLASTINE AND DACARBAZINE (APVD) FOR PATIENTS WITH UNTREATED CLASSICAL HODGKIN LYMPHOMA

Isolation and Biochemical Characterization of Lactic Acid Bacteria from Fermented Foods

Aktive Filter

Suchergebnisse filtern